Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.23K Buy
176
+84
+91% +$4.44K ﹤0.01% 1200
2026
Q1
$5.15K Buy
92
+86
+1,433% +$4.66K ﹤0.01% 1485
2025
Q4
$294 Buy
+6
New +$280 ﹤0.01% 1716
2025
Q3
Sell
-105
Closed -$4.03K 1497
2025
Q2
$4.03K Buy
105
+11
+12% +$420 ﹤0.01% 934
2025
Q1
$3.52K Buy
+94
New +$3.44K ﹤0.01% 845

Other funds holding GSK

Rossby Financial's GSK Position: Q2 2026 in Review

Rossby Financial increased its GSK (GSK) stake by 91% in Q2 2026, buying an estimated $4.44K and bringing the position to 176 shares worth $9.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Rossby Financial first reported a position in GSK in Q1 2025 and has held it in 5 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Rossby Financial held 176 shares of GSK worth $9.23K as of Q2 2026.
  • Rossby Financial bought 84 GSK shares in Q2 2026, an estimated $4.44K.
  • GSK made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1200 holding.
  • Rossby Financial first reported a position in GSK in Q1 2025 and has held it in 5 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.